d-alpha tocopherol has been researched along with amprenavir in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bridgers, A; Coffin, M; Long, S; Polli, J; Roy, A; Vickers, A; Winnike, R; Yu, L | 1 |
Fenton, M; Hall, M; Tong, C | 1 |
Annaert, P; Augustijns, P; Brouwers, J; Mols, R | 1 |
1 review(s) available for d-alpha tocopherol and amprenavir
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for d-alpha tocopherol and amprenavir
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability.
Topics: Algorithms; Animals; Biological Availability; Caco-2 Cells; Calcium Channel Blockers; Carbamates; Cell Membrane Permeability; Chromatography, High Pressure Liquid; Dogs; Furans; HIV Protease Inhibitors; Humans; Permeability; Polyethylene Glycols; Solubility; Stimulation, Chemical; Sulfonamides; Verapamil; Vitamin E | 1999 |
Using Agenerase. Nutritional considerations affect bioavailability of new P.I.
Topics: Biological Availability; Carbamates; Dietary Fats; Food-Drug Interactions; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Sulfonamides; Vitamin E | 1999 |
Validation of a differential in situ perfusion method with mesenteric blood sampling in rats for intestinal drug interaction profiling.
Topics: Adrenergic beta-Antagonists; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carbamates; Drug Interactions; Furans; Intestinal Absorption; Ketoconazole; Male; Perfusion; Polyethylene Glycols; Rats; Rats, Wistar; Splanchnic Circulation; Sulfonamides; Verapamil; Vitamin E | 2010 |